Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Skin Microbiome Modulators Market
Figure 2: Global Skin Microbiome Modulators Market (by Product), 2019 vs. 2030 ($Million)
Figure 3: Global Skin Microbiome Modulators Market (by Application), 2019 vs. 2030 ($Million)
Figure 4: Global Skin Microbiome Modulators Market (by Distribution Channel), 2019 vs. 2030 ($Million)
Figure 5: Global Skin Microbiome Modulators Market Snapshot
Figure 2.1: Global Skin Microbiome Modulators Market Segmentation
Figure 3.1: Global Skin Microbiome Modulators Market Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Human Microbiota Sites
Figure 4.2: Significant Milestones from the Human Microbiome Project (Phase 1)
Figure 4.3: Global Skin Microbiome Modulators Market, 2019-2030
Figure 4.4: Global Skin Microbiome Modulators Market: COVID-19 Impact
Figure 5.1: Funding in Microbiome Projects (FY2012-FY2016)
Figure 5.2: Specific Microbial Members/Microbial Products Investigated in Microbiome Projects
Figure 6.1: Impact Analysis
Figure 6.2: Annual NIH Funding in the Human Microbiome Research, FY2007-FY2016
Figure 6.3: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 7.1: Share of Key Developments and Strategies, January 2017-June 2020
Figure 7.2: Synergistic Activities Share (by Company), January 2017-February 2020
Figure 7.3: Business Expansion Activities Share (by Company), January 2017- June 2020
Figure 7.4: Number of Product Launches (by Company), January 2017-June 2020
Figure 7.5: Market Share Analysis for Global Skin Microbiome Modulators Market, 2018 and 2019
Figure 7.6: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Company), 2019
Figure 7.7: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Application), 2019-2030
Figure 7.8: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 8.1: Global Skin Microbiome Modulators Market (by Product Type)
Figure 8.2: Global Skin Microbiome Modulators Market (by Product Type), 2019 and 2030
Figure 8.3: Global Skin Microbiome Modulators Market (by Probiotics), 2019-2030
Figure 8.4: Global Skin Microbiome Modulators Market (by Probiotic Microbes), 2019 and 2030
Figure 8.5: Global Skin Microbiome Modulators Market (by Bacterial Probiotics), 2019 and 2030
Figure 8.6: Global Skin Microbiome Modulators Market (by Prebiotics), 2019-2030
Figure 8.7: Global Skin Microbiome Modulators Market (by Drugs), 2019-2030
Figure 9.1: Global Skin Microbiome Modulators Market (by Application)
Figure 9.2: Global Skin Microbiome Modulators Market (by Application), 2019-2030
Figure 9.3: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
Figure 9.4: Global Skin Microbiome Modulators Market (by Skin Care Applications), 2019 and 2030
Figure 9.5: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
Figure 9.6: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
Figure 10.1: Global Skin Microbiome Modulators Market (by Distribution Channels)
Figure 10.2: Global Skin Microbiome Modulators Market (by Online Channels), 2019-2030
Figure 10.3: Global Skin Microbiome Modulators Market (by Hypermarkets and Supermarkets), 2019-2030
Figure 10.4: Global Skin Microbiome Modulators Market (by Direct Selling), 2019-2030
Figure 10.5: Global Skin Microbiome Modulators Market (by Specialty Store), 2019-2030
Figure 10.6: Global Skin Microbiome Modulators Market (by Drug Stores), 2019-2030
Figure 11.1: Global Skin Microbiome Modulators Market (by Region), 2019 and 2030
Figure 11.2: Global Skin Microbiome Modulators Market (by Region), 2019-2030
Figure 11.3: Global Skin Microbiome Modulators Market Share (by Region), 2019
Figure 11.4: Global Skin Microbiome Modulators Market Share (by Region), 2030
Figure 11.5: North America Skin Microbiome Modulators Market, 2019-2030
Figure 11.6: North America: Market Dynamics
Figure 11.7: North America Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.8: U.S. Skin Microbiome Modulators Market, 2019-2030
Figure 11.9: Canada Skin Microbiome Modulators Market, 2019-2030
Figure 11.10: Europe Skin Microbiome Modulators Market, 2019-2030
Figure 11.11: Europe: Market Dynamics
Figure 11.12: Europe Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.13: Germany Skin Microbiome Modulators Market, 2019-2030
Figure 11.14: France Skin Microbiome Modulators Market, 2019-2030
Figure 11.15: U.K. Skin Microbiome Modulator Market, 2019-2030
Figure 11.16: Italy Skin Microbiome Modulators Market, 2019-2030
Figure 11.17: Spain Skin Microbiome Modulators Market, 2019-2030
Figure 11.18: Rest-of-Europe Skin Microbiome Modulators Market, 2019-2030
Figure 11.19: Asia-Pacific Skin Microbiome Modulators Market, 2019-2030
Figure 11.20: APAC: Market Dynamics
Figure 11.21: APAC Sin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.22: Japan Skin Microbiome Modulators Market, 2019-2030
Figure 11.23: China Skin Microbiome Modulators Market, 2019-2030
Figure 11.24: South Korea Skin Microbiome Modulators Market, 2019-2030
Figure 11.25: Australia Skin Microbiome Modulators Market, 2019-2030
Figure 11.26: India Skin Microbiome Modulators Market, 2019-2030
Figure 11.27: RoAPAC Skin Microbiome Modulators Market, 2019-2030
Figure 11.28: Latin America Skin Microbiome Modulators Market, 2019-2030
Figure 11.29: Latin America: Market Dynamics
Figure 11.30: Latin America Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.31: Brazil Skin Microbiome Modulators Market, 2019-2030
Figure 11.32: Mexico Skin Microbiome Modulators Market, 2019-2030
Figure 11.33: Rest-of-Latin America Skin Microbiome Modulators Market, 2019-2030
Figure 11.34: RoW Skin Microbiome Modulators Market, 2019-2030
Figure 12.1: Total Number of Companies Profiled
Figure 12.2: AOBiome (Mother Dirt): Product Portfolio
Figure 12.3: AOBiome: Pipeline Products (Drugs)
Figure 12.4: AOBiome: SWOT Analysis
Figure 12.5: Azitra, Inc.: Pipeline Products
Figure 12.6: Azitra, Inc.: SWOT Analysis
Figure 12.7: Colgate-Palmolive Company (Tom’s of Maine): Product Offerings
Figure 12.8. Colgate-Palmolive Company: Overall Financials, 2017-2019
Figure 12.9: Colgate-Palmolive Company: Revenue (by Segment), 2017-2019
Figure 12.10: Colgate-Palmolive Company.: SWOT Analysis
Figure 12.11: Evelo Biosciences, Inc.: Pipeline Products
Figure 12.12: Evelo Biosciences, Inc.: SWOT Analysis
Figure 12.13: GALLINÉE: Product Portfolio
Figure 12.14: GALLINEE.: SWOT Analysis
Figure 12.15: Glowbiotics, Inc.: Product Portfolio
Figure 12.16: Glowbiotics, Inc.: SWOT Analysis
Figure 12.17: Johnson and Jonson Services, Inc. (Aveeno): Product Portfolio
Figure 12.18: Johnson & Johnson Services, Inc. Company: Overall Financials, 2017-2019
Figure 12.19: Johnson & Johnson Services, Inc. Company: R&D Expenditure, 2017-2019
Figure 12.20: Johnson & Johnson Services, Inc.: SWOT Analysis
Figure 12.21: L’Oréal S.A.: Product Portfolio
Figure 12.22: L’Oréal S.A Company: Overall Financials, 2017-2019
Figure 12.23: L’Oreal S.A.: SWOT Analysis
Figure 12.24: MATRISYS BIOSCIENCE: Pipeline Products Portfolio
Figure 12.25: MATRISYS BIOSCIENCE: SWOT Analysis
Figure 12.26: Quorum Innovations: Pipeline Product Portfolio
Figure 12.27: Quorum Innovations: SWOT Analysis
Figure 12.28: Revlon (Elizabeth Arden, Inc.): Product Portfolio
Figure 12.29: Revlon: Overall Financials, 2017-2019
Figure 12.30: Revlon: Revenue (by Segment), 2017-2019
Figure 12.31: Revlon (Elizabeth Arden): Revenue (by Region), 2017-2019
Figure 12.32: Revlon: R&D Expenditure, 2017-2019
Figure 12.33: Revlon: SWOT Analysis
Figure 12.34: Siolta Therapeutics: Product Offerings
Figure 12.35: Siolta Therapeutics: SWOT Analysis
Figure 12.36: The Estee Lauder Companies, Inc.: Overall Product Portfolio
Figure 12.37: The Estee Lauder Companies Inc.: SWOT Analysis
Figure 12.38: TULA Life, INC: Product Portfolio
Figure 12.39: TULA Life, INC: SWOT Analysis
Figure 12.40: Unilever: Product Portfolio
Figure 12.41: Unilever: Overall Financials, 2017-2019
Figure 12.42: Unilever: Revenue (by Segment), 2017-2019
Figure 12.43: Unilever: SWOT Analysis
Figure 12.44: Yakult Honsha Co., Ltd.: Product Portfolio
Figure 12.45: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019
Figure 12.46: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019
Figure 12.47: Yakult Honsha Co., Ltd.: SWOT Analysis